Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology

dc.contributor.authorJeimy, Samira
dc.contributor.authorBen-Shoshan, Moshe
dc.contributor.authorAbrams, Elissa M
dc.contributor.authorEllis, Anne K
dc.contributor.authorConnors, Lori
dc.contributor.authorWong, Tiffany
dc.date.accessioned2020-12-01T05:07:55Z
dc.date.issued2020-11-10
dc.date.updated2020-12-01T05:07:55Z
dc.description.abstractAbstract The vast majority of individuals labelled as allergic are not deemed truly allergic upon appropriate assessment by an allergist. A label of beta-lactam allergy carries important risks for individual and public health. This article provides an overview of beta-lactam allergy, implications of erroneous beta-lactam allergy labels and the impact that can be provided by structured allergy assessment. We provide recommendations on how to stratify risk of beta-lactam allergy, beta lactam challenge protocols as well as management of patients at high risk of beta-lactam allergy.
dc.identifier.citationAllergy, Asthma & Clinical Immunology. 2020 Nov 10;16(1):95
dc.identifier.urihttps://doi.org/10.1186/s13223-020-00494-2
dc.identifier.urihttp://hdl.handle.net/1993/35146
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderThe Author(s)
dc.titlePractical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
13223_2020_Article_494.pdf
Size:
990.89 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.24 KB
Format:
Item-specific license agreed to upon submission
Description: